Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Citi
Chinese Patent Office
Merck
Fuji

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 10,285,986

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,285,986
Title:Compounds and anti-tumor NQO1 substrates
Abstract: Compositions comprising Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compositions are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.
Inventor(s): Hergenrother; Paul J. (Champaign, IL), Boothman; David A. (Dallas, TX), Bair; Joseph S. (Albany, CA), Palchaudhuri; Rahul (Cambridge, MA), Parkinson; Elizabeth I. (Champaign, IL)
Assignee: The Board of Trustees of the University of Illinois (Urbana, IL) The Board of Regents of the University of Texas System (Austin, TX)
Application Number:15/933,671
Patent Claims:see list of patent claims

Details for Patent 10,285,986

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Sign Up The Board of Trustees of the University of Illinois (Urbana, IL) The Board of Regents of the University of Texas System (Austin, TX) 2031-10-14 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Sign Up The Board of Trustees of the University of Illinois (Urbana, IL) The Board of Regents of the University of Texas System (Austin, TX) 2031-10-14 RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ➤ Sign Up The Board of Trustees of the University of Illinois (Urbana, IL) The Board of Regents of the University of Texas System (Austin, TX) 2031-10-14 RX Orphan search
Genzyme LEMTRADA alemtuzumab INJECTABLE;INJECTION 103948 003 2001-05-07 ➤ Sign Up The Board of Trustees of the University of Illinois (Urbana, IL) The Board of Regents of the University of Texas System (Austin, TX) 2031-10-14 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Argus Health
Colorcon
Healthtrust
Julphar
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.